Lifecore Biomedical
LFCR4.3001.15% ( -0.050 )
Lifecore Biomedical (LFCR)
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers i...
- Open
- 4.390
- High
- 4.510
- Low
- 4.185
- Prev. Close
- 4.350
- Volume
- 44.83K
- Turnover
- 193.06K
- Avg Price
- 4.307
- Bid/Ask Ratio
- --
- Amplitude
- 7.47%
- 52wk High
- 8.980
- Volume Ratio
- 1.04
- Turnover Ratio
- 0.23%
Lifecore Biomedical Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$6.8358.91%
Forecast & RatingBuy
5analysts
- Strong buy40.00%
- Buy20.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 1 hour ago
LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook
- Quartr · 4 hours ago
LFCR: Revenue and profit declined, with liquidity sufficient but major preferred stock redemptions looming
- Quartr · 4 hours ago
LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed
- PUBT · 4 hours ago
Lifecore Biomedical Q2 FY26 net loss widens to $6.2 million; revenue falls 6.2% to $34.2 million
- Unusual Whales · 4 hours ago
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
- Market Beat · Jul 31 at 06:00 AM
Zacks Research Upgrades Lifecore Biomedical (NASDAQ:LFCR) to Hold
